Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants With a Gestational Age of 23 0/7 - 34 6/7 Weeks

NCT03195998 is registered in ClinicalTrials.gov with Pediatrix as lead sponsor.

NCT NCT03195998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03195998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants With a Gestational Age of 23 0/7 - 34 6/7 Weeks
Lead sponsor
Pediatrix
Phase
Observational
Overall status
Completed
Start date
June 30, 2017
Completion date
February 1, 2019
Enrollment
166 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperbilirubinemia